世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のRNA医薬市場の成長（現状と展望）2024-2030年


Global RNA Medicine Market Growth (Status and Outlook) 2024-2030

LPI（LPインフォメーション）の最新調査によると、世界のRNA医薬の市場規模は2023年に100万米ドルと評価されました。川下市場での需要の増加に伴い、RNA Medicineはレビュー期間中のCAGR %で2030年までに100万米... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2024年10月8日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		126 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

LPI（LPインフォメーション）の最新調査によると、世界のRNA医薬の市場規模は2023年に100万米ドルと評価されました。川下市場での需要の増加に伴い、RNA Medicineはレビュー期間中のCAGR %で2030年までに100万米ドルの再調整された規模になると予測されています。
この調査レポートは、世界のRNA Medicine市場の成長可能性を明らかにしています。RNA医薬は今後の市場において安定した成長を示すと予想される。しかし、RNA Medicineの普及には、製品の差別化、コストの削減、サプライチェーンの最適化が依然として重要である。市場関係者は、RNA医薬品市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要があります。
世界の医薬品市場は、2022年には1,475億ドルに達し、今後6年間のCAGRは5％で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
RNA医薬市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長：この調査レポートは、RNA医薬市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分（例：siRNA、ASO）、地域別内訳などが含まれます。
市場促進要因と課題：政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、RNA医薬市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢：この調査レポートは、RNA医薬市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発：調査レポートは、RNA医薬業界における最新の技術開発を掘り下げることができます。これには、RNA Medicine技術の進歩、RNA Medicineの新規参入、RNA Medicineの新規投資、RNA Medicineの将来を形作るその他の技術革新が含まれます。
川下企業の好み：このレポートは、RNA Medicine市場における顧客の購買行動と採用動向を明らかにします。このレポートには、顧客の購買決定やRNA医薬製品の嗜好に影響を与える要因が含まれています。
政府の政策とインセンティブ：調査レポートは、政府の政策やインセンティブがRNA医薬市場に与える影響を分析します。これには、規制の枠組み、補助金、税制優遇措置、RNA Medicine市場の促進を目的としたその他の措置の評価が含まれる。また、市場成長促進におけるこれらの政策の有効性も評価する。
環境への影響と持続可能性調査レポートは、RNA医薬市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望：調査レポートは、実施した分析に基づいて、RNA医薬業界の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられている。市場関係者が新たなトレンドを活用し、課題を克服し、RNA医薬市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
RNA医薬市場はタイプ別と用途別に分類される。2019-2030年の期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
siRNA
ASO
miRNA
核酸アプタマー
用途別セグメント
癌
糖尿病
結核
心血管疾患
その他
本レポートはまた、市場を地域別に分けています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ファイザー
ロシュ
サノフィ・アベンティス
アボット・ラボラトリーズ
アローヘッド・ファーマシューティカルズ
ベニテック・バイオファーマ
カリミューン社
ディセルナ
グラダリス
クオーク
RXi
セネスコ
サイレンス・セラピューティクス
サイレンシード
テクミラ
アルナイラム製薬


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Medicine Market Size 2019-2030
2.1.2 RNA Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 RNA Medicine Segment by Type
2.2.1 siRNA
2.2.2 ASO
2.2.3 miRNA
2.2.4 Nucleic Acid Aptamers
2.3 RNA Medicine Market Size by Type
2.3.1 RNA Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global RNA Medicine Market Size Market Share by Type (2019-2024)
2.4 RNA Medicine Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Tuberculosis
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 RNA Medicine Market Size by Application
2.5.1 RNA Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global RNA Medicine Market Size Market Share by Application (2019-2024)
3 RNA Medicine Market Size by Player
3.1 RNA Medicine Market Size Market Share by Players
3.1.1 Global RNA Medicine Revenue by Players (2019-2024)
3.1.2 Global RNA Medicine Revenue Market Share by Players (2019-2024)
3.2 Global RNA Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA Medicine by Regions
4.1 RNA Medicine Market Size by Regions (2019-2024)
4.2 Americas RNA Medicine Market Size Growth (2019-2024)
4.3 APAC RNA Medicine Market Size Growth (2019-2024)
4.4 Europe RNA Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa RNA Medicine Market Size Growth (2019-2024)
5 Americas
5.1 Americas RNA Medicine Market Size by Country (2019-2024)
5.2 Americas RNA Medicine Market Size by Type (2019-2024)
5.3 Americas RNA Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Medicine Market Size by Region (2019-2024)
6.2 APAC RNA Medicine Market Size by Type (2019-2024)
6.3 APAC RNA Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA Medicine by Country (2019-2024)
7.2 Europe RNA Medicine Market Size by Type (2019-2024)
7.3 Europe RNA Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Medicine by Region (2019-2024)
8.2 Middle East & Africa RNA Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa RNA Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA Medicine Market Forecast
10.1 Global RNA Medicine Forecast by Regions (2025-2030)
10.1.1 Global RNA Medicine Forecast by Regions (2025-2030)
10.1.2 Americas RNA Medicine Forecast
10.1.3 APAC RNA Medicine Forecast
10.1.4 Europe RNA Medicine Forecast
10.1.5 Middle East & Africa RNA Medicine Forecast
10.2 Americas RNA Medicine Forecast by Country (2025-2030)
10.2.1 United States RNA Medicine Market Forecast
10.2.2 Canada RNA Medicine Market Forecast
10.2.3 Mexico RNA Medicine Market Forecast
10.2.4 Brazil RNA Medicine Market Forecast
10.3 APAC RNA Medicine Forecast by Region (2025-2030)
10.3.1 China RNA Medicine Market Forecast
10.3.2 Japan RNA Medicine Market Forecast
10.3.3 Korea RNA Medicine Market Forecast
10.3.4 Southeast Asia RNA Medicine Market Forecast
10.3.5 India RNA Medicine Market Forecast
10.3.6 Australia RNA Medicine Market Forecast
10.4 Europe RNA Medicine Forecast by Country (2025-2030)
10.4.1 Germany RNA Medicine Market Forecast
10.4.2 France RNA Medicine Market Forecast
10.4.3 UK RNA Medicine Market Forecast
10.4.4 Italy RNA Medicine Market Forecast
10.4.5 Russia RNA Medicine Market Forecast
10.5 Middle East & Africa RNA Medicine Forecast by Region (2025-2030)
10.5.1 Egypt RNA Medicine Market Forecast
10.5.2 South Africa RNA Medicine Market Forecast
10.5.3 Israel RNA Medicine Market Forecast
10.5.4 Turkey RNA Medicine Market Forecast
10.5.5 GCC Countries RNA Medicine Market Forecast
10.6 Global RNA Medicine Forecast by Type (2025-2030)
10.7 Global RNA Medicine Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer RNA Medicine Product Offered
11.1.3 Pfizer RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche RNA Medicine Product Offered
11.2.3 Roche RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Information
11.3.2 Sanofi-Aventis RNA Medicine Product Offered
11.3.3 Sanofi-Aventis RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi-Aventis Main Business Overview
11.3.5 Sanofi-Aventis Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories RNA Medicine Product Offered
11.4.3 Abbott Laboratories RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Information
11.5.2 Arrowhead Pharmaceuticals RNA Medicine Product Offered
11.5.3 Arrowhead Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Arrowhead Pharmaceuticals Main Business Overview
11.5.5 Arrowhead Pharmaceuticals Latest Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Information
11.6.2 Benitec Biopharma RNA Medicine Product Offered
11.6.3 Benitec Biopharma RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Benitec Biopharma Main Business Overview
11.6.5 Benitec Biopharma Latest Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Information
11.7.2 Calimmune Inc RNA Medicine Product Offered
11.7.3 Calimmune Inc RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Calimmune Inc Main Business Overview
11.7.5 Calimmune Inc Latest Developments
11.8 Dicerna
11.8.1 Dicerna Company Information
11.8.2 Dicerna RNA Medicine Product Offered
11.8.3 Dicerna RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Dicerna Main Business Overview
11.8.5 Dicerna Latest Developments
11.9 Gradalis
11.9.1 Gradalis Company Information
11.9.2 Gradalis RNA Medicine Product Offered
11.9.3 Gradalis RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Gradalis Main Business Overview
11.9.5 Gradalis Latest Developments
11.10 Quark
11.10.1 Quark Company Information
11.10.2 Quark RNA Medicine Product Offered
11.10.3 Quark RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quark Main Business Overview
11.10.5 Quark Latest Developments
11.11 RXi
11.11.1 RXi Company Information
11.11.2 RXi RNA Medicine Product Offered
11.11.3 RXi RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 RXi Main Business Overview
11.11.5 RXi Latest Developments
11.12 Senesco
11.12.1 Senesco Company Information
11.12.2 Senesco RNA Medicine Product Offered
11.12.3 Senesco RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Senesco Main Business Overview
11.12.5 Senesco Latest Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Information
11.13.2 Silence Therapeutics RNA Medicine Product Offered
11.13.3 Silence Therapeutics RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Silence Therapeutics Main Business Overview
11.13.5 Silence Therapeutics Latest Developments
11.14 Silenseed
11.14.1 Silenseed Company Information
11.14.2 Silenseed RNA Medicine Product Offered
11.14.3 Silenseed RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Silenseed Main Business Overview
11.14.5 Silenseed Latest Developments
11.15 Tekmira
11.15.1 Tekmira Company Information
11.15.2 Tekmira RNA Medicine Product Offered
11.15.3 Tekmira RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Tekmira Main Business Overview
11.15.5 Tekmira Latest Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Information
11.16.2 Alnylam Pharmaceuticals RNA Medicine Product Offered
11.16.3 Alnylam Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Alnylam Pharmaceuticals Main Business Overview
11.16.5 Alnylam Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

According to our LPI (LP Information) latest study, the global RNA Medicine market size was valued at US$ million in 2023. With growing demand in downstream market, the RNA Medicine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global RNA Medicine market. RNA Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNA Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNA Medicine market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on RNA Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the RNA Medicine market. It may include historical data, market segmentation by Type (e.g., siRNA, ASO), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNA Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the RNA Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the RNA Medicine industry. This include advancements in RNA Medicine technology, RNA Medicine new entrants, RNA Medicine new investment, and other innovations that are shaping the future of RNA Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNA Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for RNA Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNA Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNA Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNA Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNA Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNA Medicine market.
Market Segmentation:
RNA Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Segmentation by application
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Medicine Market Size 2019-2030
2.1.2 RNA Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 RNA Medicine Segment by Type
2.2.1 siRNA
2.2.2 ASO
2.2.3 miRNA
2.2.4 Nucleic Acid Aptamers
2.3 RNA Medicine Market Size by Type
2.3.1 RNA Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global RNA Medicine Market Size Market Share by Type (2019-2024)
2.4 RNA Medicine Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Tuberculosis
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 RNA Medicine Market Size by Application
2.5.1 RNA Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global RNA Medicine Market Size Market Share by Application (2019-2024)
3 RNA Medicine Market Size by Player
3.1 RNA Medicine Market Size Market Share by Players
3.1.1 Global RNA Medicine Revenue by Players (2019-2024)
3.1.2 Global RNA Medicine Revenue Market Share by Players (2019-2024)
3.2 Global RNA Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA Medicine by Regions
4.1 RNA Medicine Market Size by Regions (2019-2024)
4.2 Americas RNA Medicine Market Size Growth (2019-2024)
4.3 APAC RNA Medicine Market Size Growth (2019-2024)
4.4 Europe RNA Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa RNA Medicine Market Size Growth (2019-2024)
5 Americas
5.1 Americas RNA Medicine Market Size by Country (2019-2024)
5.2 Americas RNA Medicine Market Size by Type (2019-2024)
5.3 Americas RNA Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Medicine Market Size by Region (2019-2024)
6.2 APAC RNA Medicine Market Size by Type (2019-2024)
6.3 APAC RNA Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA Medicine by Country (2019-2024)
7.2 Europe RNA Medicine Market Size by Type (2019-2024)
7.3 Europe RNA Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Medicine by Region (2019-2024)
8.2 Middle East & Africa RNA Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa RNA Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA Medicine Market Forecast
10.1 Global RNA Medicine Forecast by Regions (2025-2030)
10.1.1 Global RNA Medicine Forecast by Regions (2025-2030)
10.1.2 Americas RNA Medicine Forecast
10.1.3 APAC RNA Medicine Forecast
10.1.4 Europe RNA Medicine Forecast
10.1.5 Middle East & Africa RNA Medicine Forecast
10.2 Americas RNA Medicine Forecast by Country (2025-2030)
10.2.1 United States RNA Medicine Market Forecast
10.2.2 Canada RNA Medicine Market Forecast
10.2.3 Mexico RNA Medicine Market Forecast
10.2.4 Brazil RNA Medicine Market Forecast
10.3 APAC RNA Medicine Forecast by Region (2025-2030)
10.3.1 China RNA Medicine Market Forecast
10.3.2 Japan RNA Medicine Market Forecast
10.3.3 Korea RNA Medicine Market Forecast
10.3.4 Southeast Asia RNA Medicine Market Forecast
10.3.5 India RNA Medicine Market Forecast
10.3.6 Australia RNA Medicine Market Forecast
10.4 Europe RNA Medicine Forecast by Country (2025-2030)
10.4.1 Germany RNA Medicine Market Forecast
10.4.2 France RNA Medicine Market Forecast
10.4.3 UK RNA Medicine Market Forecast
10.4.4 Italy RNA Medicine Market Forecast
10.4.5 Russia RNA Medicine Market Forecast
10.5 Middle East & Africa RNA Medicine Forecast by Region (2025-2030)
10.5.1 Egypt RNA Medicine Market Forecast
10.5.2 South Africa RNA Medicine Market Forecast
10.5.3 Israel RNA Medicine Market Forecast
10.5.4 Turkey RNA Medicine Market Forecast
10.5.5 GCC Countries RNA Medicine Market Forecast
10.6 Global RNA Medicine Forecast by Type (2025-2030)
10.7 Global RNA Medicine Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer RNA Medicine Product Offered
11.1.3 Pfizer RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche RNA Medicine Product Offered
11.2.3 Roche RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Information
11.3.2 Sanofi-Aventis RNA Medicine Product Offered
11.3.3 Sanofi-Aventis RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi-Aventis Main Business Overview
11.3.5 Sanofi-Aventis Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories RNA Medicine Product Offered
11.4.3 Abbott Laboratories RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Company Information
11.5.2 Arrowhead Pharmaceuticals RNA Medicine Product Offered
11.5.3 Arrowhead Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Arrowhead Pharmaceuticals Main Business Overview
11.5.5 Arrowhead Pharmaceuticals Latest Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Company Information
11.6.2 Benitec Biopharma RNA Medicine Product Offered
11.6.3 Benitec Biopharma RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Benitec Biopharma Main Business Overview
11.6.5 Benitec Biopharma Latest Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Company Information
11.7.2 Calimmune Inc RNA Medicine Product Offered
11.7.3 Calimmune Inc RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Calimmune Inc Main Business Overview
11.7.5 Calimmune Inc Latest Developments
11.8 Dicerna
11.8.1 Dicerna Company Information
11.8.2 Dicerna RNA Medicine Product Offered
11.8.3 Dicerna RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Dicerna Main Business Overview
11.8.5 Dicerna Latest Developments
11.9 Gradalis
11.9.1 Gradalis Company Information
11.9.2 Gradalis RNA Medicine Product Offered
11.9.3 Gradalis RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Gradalis Main Business Overview
11.9.5 Gradalis Latest Developments
11.10 Quark
11.10.1 Quark Company Information
11.10.2 Quark RNA Medicine Product Offered
11.10.3 Quark RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quark Main Business Overview
11.10.5 Quark Latest Developments
11.11 RXi
11.11.1 RXi Company Information
11.11.2 RXi RNA Medicine Product Offered
11.11.3 RXi RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 RXi Main Business Overview
11.11.5 RXi Latest Developments
11.12 Senesco
11.12.1 Senesco Company Information
11.12.2 Senesco RNA Medicine Product Offered
11.12.3 Senesco RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Senesco Main Business Overview
11.12.5 Senesco Latest Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Company Information
11.13.2 Silence Therapeutics RNA Medicine Product Offered
11.13.3 Silence Therapeutics RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Silence Therapeutics Main Business Overview
11.13.5 Silence Therapeutics Latest Developments
11.14 Silenseed
11.14.1 Silenseed Company Information
11.14.2 Silenseed RNA Medicine Product Offered
11.14.3 Silenseed RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Silenseed Main Business Overview
11.14.5 Silenseed Latest Developments
11.15 Tekmira
11.15.1 Tekmira Company Information
11.15.2 Tekmira RNA Medicine Product Offered
11.15.3 Tekmira RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Tekmira Main Business Overview
11.15.5 Tekmira Latest Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Company Information
11.16.2 Alnylam Pharmaceuticals RNA Medicine Product Offered
11.16.3 Alnylam Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Alnylam Pharmaceuticals Main Business Overview
11.16.5 Alnylam Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

LP Information社の医薬品・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（medicine）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14　10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.